Matrixing Designs for Shelf-Life Determination of Parenteral Drug Product: A Comparative Analysis of Full and Reduced Stability Testing Design
This article highlights the applicability of matrixing designs in stability studies for parenteral medications. The traditional approach involves extensive testing over the product's shelf-life. However, matrixing designs offer an alternative approach where only a fraction of samples is tested...
Saved in:
Main Authors: | Lara Pavčnik (Author), Igor Locatelli (Author), Tina Trdan Lušin (Author), Robert Roškar (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stability of Reduced and Oxidized Coenzyme Q10 in Finished Products
by: Žane Temova Rakuša, et al.
Published: (2021) -
Production and stability study of a hospital parenteral nutrition solution for neonates
by: Anne-Laure Yailian, et al.
Published: (2019) -
Design of experiment-driven stability-indicating RP-HPLC method for the determination of tofacitinib in nanoparticles and skin matrix
by: Srividya Gorantla, et al.
Published: (2021) -
All-in-One Pediatric Parenteral Nutrition Admixtures with an Extended Shelf Life-Insight in Correlations between Composition and Physicochemical Parameters
by: Aleksandra Gostyńska, et al.
Published: (2021) -
Quality by Design: Development of Safe and Efficacious Full-Thickness Acellular Dermal Matrix Based on EuroGTPII Methodologies
by: López-Chicón P, et al.
Published: (2023)